Findings suggest efficacy and safety of psilocybin in bipolar II depression and support further study of psychedelics in this population. ja.ma/3KxuCFG
A wireless system that provided daily feedback on progress in lifestyle change and weight loss was not noninferior to the same system with human coaching, finds randomized clinical trial. ja.ma/3yi7Grp#ECO2024pic.twitter.com/yp9rBIPZEJ
“When we recommend the best treatment for patients on the basis of their individual characteristics, we are applying the concept of heterogeneity of treatment effect.” Read the full editorial by Drs. Christopher J. Yarnell and @FralickMike: eviden.cc/3TuT2DPpic.twitter.com/nUZ5Vm7JoR